Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Fortress Biotech, Inc. (FBIO) had Gross Margin of 66.17% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$16.08M |
|
$-6.20M |
|
$5.44M |
|
$10.64M |
|
$20.70M |
|
$-4.62M |
|
$-1.42M |
|
$-6.04M |
|
$-6.04M |
|
$-5.40M |
|
$-5.40M |
|
$-5.40M |
|
$-5.40M |
|
$-4.62M |
|
$-2.65M |
|
27.90M |
|
27.90M |
|
$-0.22 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$123.84M |
|
$2.52M |
|
$61.71M |
|
$185.55M |
|
$49.74M |
|
$52.42M |
|
$73.62M |
|
$123.36M |
|
$62.18M |
|
$34.58M |
|
$62.18M |
|
31.36M |
|
| Cash Flow Statement Financials | |
$-65.78M |
|
$10.12M |
|
$77.44M |
|
$58.81M |
|
$80.60M |
|
$21.79M |
|
$28.74M |
|
$-0.66M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.49 |
|
-- |
|
-- |
|
0.46 |
|
0.84 |
|
|
Gross Margin |
66.17% |
-28.73% |
|
-28.73% |
|
-- |
|
-37.58% |
|
-38.54% |
|
$-64.61M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.57 |
|
0.54 |
|
167.59 |
|
-8.68% |
|
-15.61% |
|
-2.91% |
|
-4.71% |
|
$1.98 |
|
$-2.32 |
|
$-2.36 |
|